We are live on ! Find out more
NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

25 hedge funds and large institutions have $65.3M invested in NKGen Biotech, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% less funds holding

Funds holding: 55 → 25 (-30)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

61% less capital invested

Capital invested by funds: $168M → $65.3M (-$103M)

91% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 33

Holders
25
Holders Change
-30
Holders Change %
-54.55%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
11
Closed
33
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$2.58M
2
SFM
Spartan Fund Management
Canada
+$2.46M
3
WCMNY
Westchester Capital Management (New York)
New York
+$1.08M
4
Walleye Capital
Walleye Capital
New York
+$205K
5
VF
Virtu Financial
New York
+$126K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$13.7M
2
PC
Periscope Capital
Ontario, Canada
-$8.86M
3
AC
Aristeia Capital
Connecticut
-$8.17M
4
CIM
Cowen Investment Management
New York
-$7.6M
5
CSS
Cubist Systematic Strategies
Connecticut
-$5.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
26
Adage Capital Partners
Massachusetts
– -$13.7M -1,350,000 Closed
AC
27
Aristeia Capital
Connecticut
– -$8.17M -806,666 Closed
CIM
28
Cowen Investment Management
New York
– -$7.6M -750,000 Closed
CSS
29
Cubist Systematic Strategies
Connecticut
– -$5.12M -505,206 Closed
Jane Street
30
Jane Street
New York
– -$5.08M -501,815 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
31
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$5.07M -500,000 Closed
6CM
32
683 Capital Management
New York
– -$4.87M -481,190 Closed
PSAMP
33
P. Schoenfeld Asset Management (PSAM)
New York
– -$4.05M -400,000 Closed
Goldman Sachs
34
Goldman Sachs
New York
– -$3.7M -365,000 Closed
CF
35
Cantor Fitzgerald
New York
– -$3.5M -345,703 Closed
PAMP
36
Polar Asset Management Partners
Ontario, Canada
– -$3.04M -300,000 Closed
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
– -$2.56M -252,656 Closed
ETH
38
Exos TFP Holdings
New York
– -$2.53M -250,000 Closed
RL
39
RPO LLC
Connecticut
– -$2.4M -237,001 Closed
FTCM
40
First Trust Capital Management
Illinois
– -$2.03M -200,201 Closed
SCM
41
Shaolin Capital Management
Florida
– -$2.03M -200,000 Closed
Millennium Management
42
Millennium Management
New York
– -$1.55M -153,494 Closed
CH
43
CVI Holdings
Delaware
– -$1.52M -150,000 Closed
BI
44
Bulldog Investors
New Jersey
– -$1.01M -100,000 Closed
OCM
45
Oaktree Capital Management
California
– -$1.01M -100,000 Closed
SC
46
Sculptor Capital
New York
– -$1.01M -100,000 Closed
AA
47
AQR Arbitrage
Connecticut
– -$709K -70,000 Closed
DAM
48
Deltec Asset Management
New York
– -$699K -69,000 Closed
SIA
49
Schechter Investment Advisors
Michigan
– -$571K -56,398 Closed
PI
50
PEAK6 Investments
Illinois
– -$559K -55,195 Closed
1
2
3

NKGN Hedge Fund Activity: Q2 2023 in Review

25 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Common Stock (NKGN) for Q2 2023, worth a combined $65.3M — down 61% from $168M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of NKGN and 3 opened new positions — a net loss of 30 holders — while 11 trimmed existing stakes and 5 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $2.58M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $13.7M sold.

  • 25 institutional investors held NKGen Biotech, Inc. Common Stock (NKGN) as of Q2 2023, down from 55 in Q1 2023.
  • Funds reported $65.3M of NKGen Biotech, Inc. Common Stock stock for Q2 2023, down 61% quarter-over-quarter.
  • 3 funds opened new NKGen Biotech, Inc. Common Stock positions in Q2 2023 and 33 closed out, a net change of -30 holders.
  • The largest NKGen Biotech, Inc. Common Stock buyer in Q2 2023 was Fir Tree Capital Management, an estimated $2.58M added.
  • The largest NKGen Biotech, Inc. Common Stock seller in Q2 2023 was Adage Capital Partners, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2023.